Insmed (INSM +1.9%) closes it public offering of 11.5M shares of common stock, at $20.65 per share, including the full exercise of the underwriters over-allotment of 1.5M shares.
Net proceeds of ~$223M will fund the further development of ARIKAYCE, INS1009 and general corporate purposes.